Notices for publication in the OJ nº T-740/18 of Tribunal General de la Unión Europea, February 08, 2019

• Resolution Date: February 08, 2019
• Issuing Organization: Tribunal General de la Unión Europea
• Decision Number: T-740/18

Action brought on 18 December 2018 - Taminco and Arysta LifeScience Great Britain v Commission

(Case T-740/18)

Language of the case: English

Parties

Applicants: Taminco BVBA (Gent, Belgium) and Arysta LifeScience Great Britain Ltd (Edinburgh, United Kingdom) (represented by: C. Mereu and M. Grunchard, lawyers)

Defendant: European Commission

Form of order sought

The applicants claim that the Court should:

annul Commission Implementing Regulation (EU) 2018/1500 of 9 October 2018 concerning the non-renewal of approval of the active substance Thiram, and prohibiting the use and sale of seeds treated with plant protection products containing Thiram, ¹ and remand the assessment of the active substance in question to the European Food Safety Authority (EFSA) and the defendant, as needed;

order the prolongation of the expiry of the approval of the active substance in question to allow its reassessment;

in the alternative, partially annul the contested regulation to the extent that it prohibits the renewal of the active substance in question with regard to seed treatment; and

order the defendant to pay all the costs.

Pleas in law and main arguments

In support of the action, the applicants rely on six pleas in law.

First plea in law, alleging that the contested regulation is procedurally flawed since the defendant failed to take into account the withdrawal of the application requested by the applicants to renew the approval of Thiram for use as a foliar spray and maintain only the seed treatment use.

Second plea in law, alleging that the contested regulation was adopted further to a manifest error of assessment.

Third plea in law, alleging that the contested regulation was adopted in violation of Article 4(5) of Regulation (EC) No 1107/2009. ²

Fourth plea in law, alleging that the defendant acted ultra vires by making a proposal regarding the classification of the active substance in question.

Fifth plea in law, alleging...